Altair (Nasdaq: ALTR), a global leader in computational intelligence, has announced a partnership with CGI, one of the ...
Yasmina Hayek, executive chef of the globally acclaimed restaurant group, Em Sherif, has been named the Middle East & North ...
Viral K-Beauty brand, COSRX launches the Advanced Snail Mucin Glass Glow Hydrogel Mask, the latest addition to its award ...
CALGARY, AB, Dec. 12, 2024 /PRNewswire/ - Frontera Energy Corporation (TSX: FEC) ("Frontera" or the "Company") today provided an operational update and announced its full year 2025 capital and ...
BOSTON, Dec. 12, 2024 /PRNewswire/ -- Bamboo Rose, a global leader in retail product development and supply chain technology, has achieved a remarkable milestone: retail revenue under management has ...
Wirex, a leading Web3 money app, is excited to introduce the Visa Platinum card for its UK customers, offering a range of ...
All cash offer of $1.67 per share representing a 58% premium to O3 Mining's closing price on December 11, 2024 Offer unanimously recommended by Board and Special Committee of O3 Mining and supported ...
-- 2025 adjusted diluted EPS of greater than $7.25 -- -- Reaffirms 2024 adjusted diluted EPS guidance of greater than $6.80 -- ST. LOUIS, Dec. 12, 2024 /PRNewswire/ -- Centene Corporation (NYSE: CNC) ...
SAN DIEGO, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small ...
VILNIUS, LT / ACCESSWIRE / December 12, 2024 / FreeBnk, an innovative neobank bridging the gap between traditional and decentralized finance, has unveiled its new Crypto Visa Card, bringing seamless c ...
FORT LAUDERDALE, FL / ACCESSWIRE / December 12, 2024 / FAVO Capital, Inc. (OTC PINK:FAVO), a leading provider of alternative financing solutions in the Private Credit Sector, today announced that it h ...
Opportunistic acquisition adds Phase 2 novel checkpoint inhibitor (KVA12123) to TuHURA's late stage pipelineTargeting Phase 2a/b trial with KVA12123 in mutated NPM1 AML in 2025Cross product and techno ...